Enhancements    

IDENTIFICATION OF NOVEL ANTIAPOPTOTIC PROTEIN SIGNALING COMPLEXES AS NEW THERAPEUTIC TARGETS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES

IDENTIFICATION OF NOVEL ANTIAPOPTOTIC PROTEIN SIGNALING COMPLEXES AS NEW THERAPEUTIC TARGETS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES
PI: Elisa Robles Escajeda
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
Biological Sciences
Amount awarded: $70,000

This grant studies the efficacy of novel drugs that target Prohibitins and pro-survival proteins associated with hematological cancers, such as leukemia and lymphoma; and explores new options to identify oncogenic mutations and their association with the activation of anti-apoptotic proteins in primary patient samples.

Posting date: Thu, 04/19/2018

Award start date: Fri, 06/01/2018
Award end date: Thu, 01/31/2019